Skip to main content
OpenTrials

Clinical trial condition

TP53 Y220C Mutation

Explore clinical trials studying TP53 Y220C Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

TP53 Y220C Mutation trial results

Recruiting

A Study to Investigate the Effects of Multiple Doses of Rezatapopt on the Pharmacokinetics of Metformin, Rosuvastatin, Repaglinide, and Midazolam in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation.

NCT07372625

Conditions
Advanced Solid Tumors, TP53 Y220C Mutation
Locations
  • HealthOne Denver Denver, Colorado, United States
  • Florida Cancer Specialists Orlando, Florida, United States
  • SCRI Oncology Partners Nashville, Tennessee, United States
  • SCRI at Mary Crowley Dallas, Texas, United States
View Trial Details

Related conditions